Preventive stRategy for IMMU132-relatED AEs in TNBC

Conditions:   Triple Negative Breast Cancer;   Breast Cancer Interventions:   Drug: Sacituzumab govitecan;   Drug: Loperamide;   Drug: Granulocyte Colony-Stimulating Factor Sponsors:   MedSIR;   Gilead Sciences Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials